Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Disease area: Thoracic oncology

Abstract

Introduction: Recurrent non-malignant pleural effusions are common and difficult to treat. There is limited experience with the use of the PleurX catheter in the management of non-malignant pleural effusions. The purpose of this study is to evaluate the effectiveness of the PleurX catheter in non-malignant pleural effusions.
Methods: All subjects who underwent a PleurX catheter were evaluated. Demographic data, time to pleurodesis, complications, and a satisfaction questionnaire were collected. The subjects were divided into two groups. Group I included non-malignant effusions, and group II included malignant effusions.
Results: 64 subjects were included in the final analysis. 23 in group I, and 41 in group II. Table 1 summarizes the results. Time to pleurodesis was significantly shorter in hepatic hydrothorax compared to CHF (73.6 ± 9 days versus 113 ± 36 days, p=0.006). There was one case of exit site infection in a patient with hepatic hydrothorax. In subjects who were alive at three months, none had recurrence of their pleural effusion.
Conclusion: The PleurX catheter was effective in achieving pleurodesis in non-malignant pleural effusions. The complication rate was low and patient satisfaction was high.

Table 1: Outcomes of patients with malignant versus non-malignant pleural effusions

	Non-malignant	Malignant	p value
Number	23	41
Age (years)	69±13	71±13	NS
Men n (%)	13 (57%)	18 (44%)	NS
Women n (%)	10 (43%)	23 (56%)	NS
Time to pleurodesis	110.8±41	36±12	< 0.0001
Complications	1	0	NS
Recurrence at 3 months	0	0	NS
Satisfaction score	3.8±0.4	3.8±0.4	NS

Results are mean ± standard deviation. NS = Non-significant.

Rating:

Share or cite this content

Citations should be made in the following way:
M. Chalhoub, G. Bourjeily, K. Harris (Staten Island, United States Of America). The use of the PleurX catheter in the management of recurrent non-malignant pleural effusions. Eur Respir J 2010; 36: Suppl. 54, 233

Member's Comments

No comment yet.

Related content which might interest you: The use of untunneled indwelling pleural catheters for non-malignant pleural effusions in the outpatient Source: International Congress 2018 – Pleural effusions, infections and tumours Year: 2018 Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019 Efficacy and complications of small-bore catheters in the management of malignant pleural effusions Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007 Malignant pleural effusion management by tunneled pleural catheter Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Utility of indwelling pleural catheters in benign pleural effusions: A single centre experience Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS) Year: 2017 Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Indwelling pleural catheters vs. pleurodesis for malignant pleural effusions: a meta-analysis Source: International Congress 2018 – Pleural interventions Year: 2018 The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001 Ultrasonographic predictors of spontaneous pleurodesis in malignant pleural effusion with pleural tunnelled catheters Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 Tunnelled indwelling pleural catheters and trapped lung in malignant mesothelioma Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Catheter tract metastasis in mesothelioma patients with indwelling pleural catheters Source: International Congress 2018 – Cryobiopsy in interstitial lung disease (ILD) Year: 2018 Efficacy of doxycycline with small-bore catheters in patients with malignant pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Talc pelurodesis vs tunneled pleural drainage in the malignant pleural effusion Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS) Year: 2017 Use of transthoracic ultrasonography, indwelling pleural catheter and thoracoscopy for the management of malignant pleural effusion Source: International Congress 2019 – PG9 Interventional pulmonology Year: 2019 An analysis of indwelling pleural catheter (IPC) insertions for malignant pleural effusions Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011 LATE-BREAKING ABSTRACT: Spontaneous pleurodesis rates in chemotherapy and non-chemotherapy patients undergoing indwelling pleural catheter insertion for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Indwelling pleural catheters for refractory transudative effusions: a tertiary centre experience Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Feasibility and complications of nelaton catheter insertion after pleural biopsy as a novel method for pleural effusion drainage Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011 Novel mouse model of indwelling pleural catheter in mice with malignant pleural effusion Source: ERJ Open Res, 5 (2) 00226-2018; 10.1183/23120541.00226-2018 Year: 2019